Sandoz Can't Expand Xarelto Damages Claim Against Bayer

A London court said Tuesday that Bayer's mindset in seeking interim injunctions to protect its now-revoked patent for the blood-thinning drug Xarelto "makes no difference" to Sandoz's claim for damages, refusing...

Already a subscriber? Click here to view full article